TherapeuticsMD, Inc.
TXMD
Rank in Stocks
#26563
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to... TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17Γ-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception. In its developmental pipeline, TherapeuticsMD is advancing several preclinical candidates: TX-005HR, a transdermal cream containing only progesterone; TX-006HR, another transdermal cream formulated with both estradiol and progesterone; TX-007HR and TX-008HR, both experimental transdermal patches; and TX-009HR, an oral formulation of progesterone and estradiol. Beyond its core pharmaceutical offerings, the company produces and distributes both branded and generic prescription prenatal vitamins, notably under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 labels. Its prescription medications and prenatal vitamin lines reach consumers through established channels, including wholesale and retail pharmacy distributors. Established in 2008, TherapeuticsMD, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Share Price
$1.69
Last synced: 2026-11-09
Market Cap
$19.56M
Change (1 day)
-2.87%
Change (1 year)
3.05%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TherapeuticsMD, Inc. (TXMD)
Category
Healthcare
Operating Margin for TherapeuticsMD, Inc. (TXMD)
Operating Margin as of November 2026 TTM: -117.80%
According to TherapeuticsMD, Inc.'s latest financial reports, its current operating margin (TTM) is -117.80%. At the end of 2025 the company had an operating margin of -139.44%.
Operating Margin history for TherapeuticsMD, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -117.80% | -15.52% |
| 2025 | -139.44% | -48.41% |
| 2024 | -270.30% | -58.71% |
| 2023 | -654.61% | -38,606.47% |
| 2022 | 1.70% | -100.05% |
| 2021 | -3,092.77% | 1,189.89% |
| 2020 | -239.77% | -21.27% |
| 2019 | -304.56% | -62.35% |
| 2018 | -808.85% | 74.81% |
| 2017 | -462.69% | -0.77% |
| 2016 | -466.27% | 10.25% |
| 2015 | -422.93% | 17.59% |
| 2014 | -359.65% | 22.29% |
| 2013 | -294.09% | -30.47% |
| 2012 | -422.95% | 62.74% |
| 2011 | -259.90% | -73.22% |
| 2010 | -970.53% | -93.77% |
| 2009 | -15,570.87% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | -100.00% |
| 2006 | 48.63% | 30.24% |
| 2005 | 37.34% | 18.02% |
| 2004 | 31.64% | 33.00% |
| 2003 | 23.79% | -31.06% |
| 2002 | 34.51% | 86.54% |
| 2001 | 18.50% | -48.30% |
| 2000 | 35.78% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.16% |
DE
|
|
| 19.68% | -100.17% |
DE
|
|
| 13.26% | -100.11% |
JP
|
|
| 17.08% | -100.14% |
CH
|
|
| 14.92% | -100.13% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TherapeuticsMD, Inc.'s operating margin
What is TherapeuticsMD, Inc.'s operating margin?
TherapeuticsMD, Inc.'s operating margin is -117.80%, as of Nov 2026.
What was TherapeuticsMD, Inc.'s operating margin in 2025?
In 2025, TherapeuticsMD, Inc.'s operating margin was -139.44%, compared with -270.30% in 2024.
How has TherapeuticsMD, Inc.'s operating margin changed since 2020?
From 2020 to 2025, TherapeuticsMD, Inc.'s operating margin was highest in 2022 (1.70%) and lowest in 2021 (-3,092.77%).
How does TherapeuticsMD, Inc.'s operating margin compare with similar companies?
TherapeuticsMD, Inc.'s operating margin (-117.80%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.